⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL1154841 | 0.85 | — | — | |
| SCHEMBL242746 | 0.85 | CYP2C9 (0.31) | — | |
| SCHEMBL2825298 | 0.85 | CYP2C9 (0.31) | — | |
| Hydrochloric Acid SCHEMBL28813180 | 0.80 | — | — | |
| SCHEMBL29107328 | 0.80 | — | — | |
| Bromide SCHEMBL4768118 | 0.80 | — | — | |
| SCHEMBL2828669 | 0.80 | — | — | |
| Adamantane SCHEMBL8979787 | 0.80 | CYP2C9 (0.38) | — | |
| Hydrogen Peroxide SCHEMBL28741420 | 0.76 | CYP2C9 (0.35) | — | |
| Hydrazine SCHEMBL28816515 | 0.73 | LMNA (0.32) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2008130550-A1 | DIAMONDOID DERIVATIVES POSSESSING THERAPEUTIC ACTIVITY IN THE TREATMENT OF NEUROLOGIC DISORDERS | CHEVRON U.S.A, INC. (US) | 2008-10-30 | — | — | WO | disclosed |
| EP-1982970-A1 | Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders | Chevron USA, Inc. (US) | 2008-10-22 | — | — | EP | disclosed |
| EP-1885689-A1 | DIAMONDOID DERIVATIVES POSSESSING THERAPEUTIC ACTIVITY | Chevron U.S.A., Inc. (US) | 2008-02-13 | — | — | EP | disclosed |
| US-20080009546-A1 | Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders | CHEVRON U.S.A. INC. (US) | 2008-01-10 | — | — | US | disclosed |
| US-20060258748-A1 | Diamondoid derivatives possessing therapeutic activity in the treatment of neurologic disorders | CHEVRON U.S.A. INC. (US) | 2006-11-16 | — | — | US | disclosed |
| WO-2006122054-A1 | DIAMONDOID DERIVATIVES POSSESSING THERAPEUTIC ACTIVITY | CHEVRON U.S.A. INC. (US) | 2006-11-16 | — | — | WO | disclosed |